monday.com Hit With Securities Lawsuit Over Growth Forecasts

GlobeNewswire Inc.GlobeNewswire Inc.
|||5 min read
Key Takeaway

Rosen Law Firm urges monday.com investors to meet May 2026 deadline in securities fraud lawsuit alleging false growth claims.

monday.com Hit With Securities Lawsuit Over Growth Forecasts

monday.com Hit With Securities Lawsuit Over Growth Forecasts

Rosen Law Firm, a prominent investor advocacy organization, is urging shareholders in monday.com Ltd. ($MNDY) to retain legal counsel ahead of a critical May 11, 2026 deadline to serve as lead plaintiff in an ongoing securities class action. The litigation centers on allegations that company executives issued materially false or misleading statements regarding the platform's revenue expansion trajectory and sales performance during a six-month window in 2025 and early 2026.

The Legal Challenge and Allegations

The class action lawsuit targets investors who purchased monday.com common stock between September 17, 2025 and February 6, 2026—a period when the work management software company's stock may have been trading at artificially inflated levels. According to the complaint, defendants made statements that misrepresented or failed to disclose material facts concerning:

  • Decelerating revenue growth trends that contradicted public guidance
  • Extended sales cycles that hindered new customer acquisition
  • The company's ability to sustain its previously projected expansion rates

These allegations suggest that investors relied on overly optimistic projections when making their investment decisions during this seven-month period. The May 11, 2026 deadline marks a crucial juncture—investors who purchased shares during the class period must take action to preserve their legal rights and potentially participate in any recovery.

Rosen Law Firm's public reminder underscores the significance of this date, as lead plaintiff designation carries weight in class action proceedings and can influence settlement terms and litigation strategy. The firm specializes in securities litigation and investor protection, frequently representing shareholders in high-profile cases against public companies.

Market Context and Industry Backdrop

monday.com operates in the highly competitive work management and project collaboration software sector, competing against platforms like Asana ($ASAN), Atlassian ($TEAM), and Microsoft's suite of productivity tools. The sector has experienced significant volatility in recent years as investors reassess growth expectations for software-as-a-service (SaaS) companies.

The period covered by the lawsuit—fall 2025 through early 2026—represents a challenging environment for growth-stage software companies. Many SaaS platforms have faced headwinds including:

  • Macro economic pressures affecting corporate technology spending
  • Shifting customer acquisition patterns as businesses optimize budgets
  • Increased competition from both established and emerging platforms
  • Higher customer churn rates as organizations consolidate tools

For monday.com specifically, the alleged misstatements regarding slowing revenue expansion and prolonged sales cycles reflect challenges that have plagued the broader software industry. If the defendants knowingly or recklessly omitted material information about these operational difficulties, shareholders would have grounds for pursuing damages.

The timing of the lawsuit suggests that the gap between publicly stated expectations and actual business performance may have been significant enough to trigger investigations and legal action. This pattern—companies overstating growth prospects only to revise guidance downward—has become increasingly common in the post-pandemic technology landscape.

Investor Implications and Legal Considerations

For shareholders who purchased monday.com stock during the class period, this lawsuit represents a potential avenue to recover losses attributable to what securities law terms "securities fraud." The legal threshold requires proving that defendants made materially false statements with scienter (intent to deceive or recklessness), that investors relied on those statements, and that they suffered economic damages as a result.

The May 11, 2026 deadline is not merely procedural—it determines who may participate in the litigation and who may be eligible for any eventual settlement proceeds or judgment award. Investors who miss this deadline face potential bar from participation, making timely action essential.

Key considerations for affected shareholders:

  • Documentation of purchases: Investors should gather records showing the dates and prices of $MNDY stock purchases between September 17, 2025 and February 6, 2026
  • Damages calculation: Potential recovery depends on proving that shares were purchased above the "true value" based on non-fraudulent information
  • Lead plaintiff selection: The court will appoint a lead plaintiff whose attorneys will guide the litigation; investors interested in this role should contact counsel promptly
  • Settlement vs. trial: Most securities class actions settle, typically for 15-30% of claimed damages after attorney fees

The existence of such litigation can impact monday.com's reputation, customer retention, and ability to attract institutional investors. Ongoing legal proceedings create uncertainty around the company's financial obligations and management credibility—factors that typically weigh on stock valuations.

Broader market implications include potential ripple effects across the SaaS sector, as this case reinforces investor scrutiny of growth projections and disclosure practices among software companies. Other platforms with aggressive expansion narratives may face heightened pressure to substantiate claims with conservative guidance.

Forward Outlook

The May 11, 2026 lead plaintiff deadline represents a critical juncture for monday.com shareholders seeking to pursue legal remedies. With Rosen Law Firm and other plaintiff attorneys actively recruiting class members, the path is clear for affected investors to join the litigation and potentially recover damages. The outcome of this case—whether through settlement or trial—will influence how the software industry approaches growth disclosures and revenue projections, making it consequential beyond monday.com itself. Shareholders should consult with securities counsel immediately to assess eligibility and determine next steps before the deadline arrives.

Source: GlobeNewswire Inc.

Back to newsPublished 3h ago

Related Coverage

GlobeNewswire Inc.

Rosen Law Firm Files Securities Class Action Against $LU on Behalf of Defrauded Investors

Rosen Law Firm filed a securities class action against Lufax Holding Ltd, alleging false statements and inadequate financial disclosures. Investors have until May 20, 2026 to join.

LU
GlobeNewswire Inc.

Lufax Faces Securities Lawsuit Over Alleged Control Deficiencies

Rosen Law Firm files class action against $LU over false statements regarding internal controls and financial reporting. Investors who purchased securities between April 2023 and January 2025 may be eligible.

LU
GlobeNewswire Inc.

ImmunityBio Plunges 21% After FDA Warning Over Unsupported Cancer Claims

ImmunityBio shares plunge 21% after FDA warning over unsupported cancer treatment claims, erasing $2 billion in market value and triggering securities litigation.

IBRX
The Motley Fool

ANI Pharma Revenue Surges 44% to $883M; Insider Sale Signals Confidence

ANI Pharma posts record $883M revenue (up 44% YoY) with rare disease growth driving performance; insider sells 4,772 shares amid $1B+ 2026 guidance.

ANIP
GlobeNewswire Inc.

Paul Mueller Posts Strong 2025: Q4 Sales Surge 33.6% as Backlog Nearly Doubles

Paul Mueller Company reported robust 2025 earnings with Q4 sales up 33.6% and full-year net income climbing 16.9%, supported by a surging $243.6M backlog.

MUEL
GlobeNewswire Inc.

Picard Medical Investors Face April Deadline in Securities Fraud Class Action

Rosen Law Firm urges $PMI investors to join class action over alleged fraudulent stock promotion scheme involving social media misinformation and insider dumping.

PMI